IDO2 Genetic Status Informs the Neoadjuvant Efficacy of Chloroquine (CQ) in Brain Metastasis Radiotherapy

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

August 31, 2013

Study Completion Date

August 31, 2013

Conditions
Brain Metastasis
Interventions
DRUG

Chloroquine diphosphate

250 mg chloroquine once a day by mouth beginning one week prior to beginning radiation therapy and continue for a total of five weeks

Trial Locations (1)

19096

Lankenau Medical Center, Wynnewood

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Main Line Health

OTHER